Cargando…

Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study

INTRODUCTION: Prevalence of iron deficiency (ID) at intensive care (ICU) admission is around 25 to 40%. Blood losses are important during ICU stay, leading to iron losses, but prevalence of ID at ICU discharge is unknown. ID has been associated with fatigue and muscular weakness, and may thus impair...

Descripción completa

Detalles Bibliográficos
Autores principales: Lasocki, Sigismond, Chudeau, Nicolas, Papet, Thibaut, Tartiere, Deborah, Roquilly, Antoine, Carlier, Laurence, Mimoz, Olivier, Seguin, Philippe, Malledant, Yannick, Asehnoune, Karim, Hamel, Jean François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219000/
https://www.ncbi.nlm.nih.gov/pubmed/25529060
http://dx.doi.org/10.1186/s13054-014-0542-9
_version_ 1782342514649333760
author Lasocki, Sigismond
Chudeau, Nicolas
Papet, Thibaut
Tartiere, Deborah
Roquilly, Antoine
Carlier, Laurence
Mimoz, Olivier
Seguin, Philippe
Malledant, Yannick
Asehnoune, Karim
Hamel, Jean François
author_facet Lasocki, Sigismond
Chudeau, Nicolas
Papet, Thibaut
Tartiere, Deborah
Roquilly, Antoine
Carlier, Laurence
Mimoz, Olivier
Seguin, Philippe
Malledant, Yannick
Asehnoune, Karim
Hamel, Jean François
author_sort Lasocki, Sigismond
collection PubMed
description INTRODUCTION: Prevalence of iron deficiency (ID) at intensive care (ICU) admission is around 25 to 40%. Blood losses are important during ICU stay, leading to iron losses, but prevalence of ID at ICU discharge is unknown. ID has been associated with fatigue and muscular weakness, and may thus impair post-ICU rehabilitation. This study assessed ID prevalence at ICU discharge, day 28 (D28) and six months (M6) after and its relation with fatigue. METHODS: We conducted this prospective, multicenter observational study at four University hospitals ICUs. Anemic (hemoglobin (Hb) less than 13 g/dL in male and less than 12 g/dL in female) critically ill adult patients hospitalized for at least five days had an iron profile taken at discharge, D28 and M6. ID was defined as ferritin less than 100 ng/L or less than 300 ng/L together with a transferrin saturation less than 20%. Fatigue was assessed by numerical scale and the Multidimensional Fatigue Inventory-20 questionnaire at D28 and M6 and muscular weakness by a hand grip test at ICU discharge. RESULTS: Among 107 patients (men 77%, median (IQR) age 63 (48 to 73) years) who had a complete iron profile at ICU discharge, 9 (8.4%) had ID. At ICU discharge, their hemoglobin concentration (9.5 (87.7 to 10.3) versus 10.2 (92.2 to 11.7) g/dL, P =0.09), hand grip strength (52.5 (30 to 65) versus 49.5 (15.5 to 67.7)% of normal value, P =0.61) and visual analog scale fatigue scale (57 (40 to 80) versus 60 (47.5 to 80)/100, P =0.82) were not different from non-ID patients. At D28 (n =80 patients) and M6 (n =78 patients), ID prevalence increased (to 25 and 35% respectively) while anemia prevalence decreased (from 100% to 80 and 25% respectively, P <0.0001). ID was associated with increased fatigue at D28, after adjustment for main confounding factors, including anemia (regression coefficient (95%CI), 3.19 (0.74 to 5.64), P =0.012). At M6, this association disappeared. CONCLUSIONS: The prevalence of ID increases from 8% at discharge to 35% six months after prolonged ICU stay (more than five days). ID was associated with increased fatigue, independently of anemia, at D28.
format Online
Article
Text
id pubmed-4219000
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42190002014-11-05 Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study Lasocki, Sigismond Chudeau, Nicolas Papet, Thibaut Tartiere, Deborah Roquilly, Antoine Carlier, Laurence Mimoz, Olivier Seguin, Philippe Malledant, Yannick Asehnoune, Karim Hamel, Jean François Crit Care Research INTRODUCTION: Prevalence of iron deficiency (ID) at intensive care (ICU) admission is around 25 to 40%. Blood losses are important during ICU stay, leading to iron losses, but prevalence of ID at ICU discharge is unknown. ID has been associated with fatigue and muscular weakness, and may thus impair post-ICU rehabilitation. This study assessed ID prevalence at ICU discharge, day 28 (D28) and six months (M6) after and its relation with fatigue. METHODS: We conducted this prospective, multicenter observational study at four University hospitals ICUs. Anemic (hemoglobin (Hb) less than 13 g/dL in male and less than 12 g/dL in female) critically ill adult patients hospitalized for at least five days had an iron profile taken at discharge, D28 and M6. ID was defined as ferritin less than 100 ng/L or less than 300 ng/L together with a transferrin saturation less than 20%. Fatigue was assessed by numerical scale and the Multidimensional Fatigue Inventory-20 questionnaire at D28 and M6 and muscular weakness by a hand grip test at ICU discharge. RESULTS: Among 107 patients (men 77%, median (IQR) age 63 (48 to 73) years) who had a complete iron profile at ICU discharge, 9 (8.4%) had ID. At ICU discharge, their hemoglobin concentration (9.5 (87.7 to 10.3) versus 10.2 (92.2 to 11.7) g/dL, P =0.09), hand grip strength (52.5 (30 to 65) versus 49.5 (15.5 to 67.7)% of normal value, P =0.61) and visual analog scale fatigue scale (57 (40 to 80) versus 60 (47.5 to 80)/100, P =0.82) were not different from non-ID patients. At D28 (n =80 patients) and M6 (n =78 patients), ID prevalence increased (to 25 and 35% respectively) while anemia prevalence decreased (from 100% to 80 and 25% respectively, P <0.0001). ID was associated with increased fatigue at D28, after adjustment for main confounding factors, including anemia (regression coefficient (95%CI), 3.19 (0.74 to 5.64), P =0.012). At M6, this association disappeared. CONCLUSIONS: The prevalence of ID increases from 8% at discharge to 35% six months after prolonged ICU stay (more than five days). ID was associated with increased fatigue, independently of anemia, at D28. BioMed Central 2014-09-30 2014 /pmc/articles/PMC4219000/ /pubmed/25529060 http://dx.doi.org/10.1186/s13054-014-0542-9 Text en © Lasocki et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Lasocki, Sigismond
Chudeau, Nicolas
Papet, Thibaut
Tartiere, Deborah
Roquilly, Antoine
Carlier, Laurence
Mimoz, Olivier
Seguin, Philippe
Malledant, Yannick
Asehnoune, Karim
Hamel, Jean François
Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study
title Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study
title_full Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study
title_fullStr Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study
title_full_unstemmed Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study
title_short Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study
title_sort prevalence of iron deficiency on icu discharge and its relation with fatigue: a multicenter prospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219000/
https://www.ncbi.nlm.nih.gov/pubmed/25529060
http://dx.doi.org/10.1186/s13054-014-0542-9
work_keys_str_mv AT lasockisigismond prevalenceofirondeficiencyonicudischargeanditsrelationwithfatigueamulticenterprospectivestudy
AT chudeaunicolas prevalenceofirondeficiencyonicudischargeanditsrelationwithfatigueamulticenterprospectivestudy
AT papetthibaut prevalenceofirondeficiencyonicudischargeanditsrelationwithfatigueamulticenterprospectivestudy
AT tartieredeborah prevalenceofirondeficiencyonicudischargeanditsrelationwithfatigueamulticenterprospectivestudy
AT roquillyantoine prevalenceofirondeficiencyonicudischargeanditsrelationwithfatigueamulticenterprospectivestudy
AT carlierlaurence prevalenceofirondeficiencyonicudischargeanditsrelationwithfatigueamulticenterprospectivestudy
AT mimozolivier prevalenceofirondeficiencyonicudischargeanditsrelationwithfatigueamulticenterprospectivestudy
AT seguinphilippe prevalenceofirondeficiencyonicudischargeanditsrelationwithfatigueamulticenterprospectivestudy
AT malledantyannick prevalenceofirondeficiencyonicudischargeanditsrelationwithfatigueamulticenterprospectivestudy
AT asehnounekarim prevalenceofirondeficiencyonicudischargeanditsrelationwithfatigueamulticenterprospectivestudy
AT hameljeanfrancois prevalenceofirondeficiencyonicudischargeanditsrelationwithfatigueamulticenterprospectivestudy
AT prevalenceofirondeficiencyonicudischargeanditsrelationwithfatigueamulticenterprospectivestudy